Mini Review
Accepted on 21 Oct 2025
Immunometabolic Integration in Therapeutic Strategies for Managing MASLD
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1693753
Type at least 3 characters
1,247 articles
Clinical Trial
Accepted on 20 Oct 2025
Atorvastatin as an Immunomodulatory Adjunct in Ulcerative Colitis, Beyond Lipid Lowering to Inflammation Control: A Randomized Controlled Pilot Study
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1690513
- 112 views
Original Research
Published on 20 Oct 2025
Therapeutic effects of three-strain probiotic combination on slow transit constipation: mechanistic insights into MAPK signaling pathway and gut microbiota restoration
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1684442
- 937 views
Original Research
Published on 20 Oct 2025
The use of magnesium sulfate can reduce the mortality risk of cirrhosis patients: a retrospective cohort study
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1551495
- 843 views
Systematic Review
Accepted on 17 Oct 2025
The Impact of Proton Pump Inhibitor Exposure on Pneumonia: An Updated Meta-Analysis Based on Randomized Controlled Trials
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1713256
- 165 views
Perspective
Accepted on 17 Oct 2025
Not Quite a Cure Yet: Unlocking the Unfulfilled Promise of Live Biotherapeutics for Disease Treatment
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695976
Original Research
Accepted on 15 Oct 2025
Oral administration of the probiotic strain Lactobacillus helveticus BGRA43 reduces high-fat diet–induced hepatic steatosis in mice and restores gut microbiota composition
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1688777
- 133 views
Original Research
Accepted on 15 Oct 2025
Rituximab in PR3-ANCA Positive Patients with Moderately to Severely Active Ulcerative Colitis: A Multicenter Real-World Pilot Study
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1621795
- 194 views
Clinical Trial
Accepted on 15 Oct 2025
Determination of the Effective Dose of Oliceridine Combined with Propofol Using the Modified Dixon's Up-and-Down Method in Painless Gastroscopy
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620158
Original Research
Published on 15 Oct 2025
Efficacy and safety of live combined Bacillus subtilis and Enterococcus faecium in patients with constipation: a meta-analysis of randomized controlled trials
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1688544
- 1,192 views
Original Research
Accepted on 13 Oct 2025
Effects of different opioids on the contractile tension of isolated rat intestinal smooth muscle
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1617936
- 104 views
Mini Review
Published on 13 Oct 2025
The role of cuproptosis in the occurrence and development of gastric cancer
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1664200
- 409 views
Original Research
Published on 09 Oct 2025
Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis and experimental validation
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1674693
- 1,182 views
Original Research
Published on 08 Oct 2025
Barnesiella intestinihominis improves gut microbiota disruption and intestinal barrier integrity in mice with impaired glucose regulation
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1635579
- 1,325 views
Original Research
Published on 08 Oct 2025
Proton pump inhibitor use and pancreatic risk: evidence from the UK biobank participants and animal experiments
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1673200
- 922 views
Review
Published on 03 Oct 2025
The endocannabinoid system as a therapeutic target in intestinal fibrosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669951
- 1,894 views